The Application of Molecular Imaging to Advance Translational Research in Chronic Inflammation

Overview

Journal J Nucl Cardiol

Specialty Cardiology & Vascular Diseases

Date 2020 Nov 27

PMID 33244675

Citations 7

Authors

Wunan Zhou

Amit Dey

Grigory Manyak

Meron Teklu

Nidhi Patel

Heather Teague

Nehal N Mehta

Affiliations

Soon will be listed here.

Abstract

Over the past several decades, molecular imaging techniques to assess cellular processes in vivo have been integral in advancing our understanding of disease pathogenesis. F-fluorodeoxyglucose (18-FDG) positron emission tomography (PET) imaging in particular has shaped the field of atherosclerosis research by highlighting the importance of underlying inflammatory processes that are responsible for driving disease progression. The ability to assess physiology using molecular imaging, combining it with anatomic delineation using cardiac coronary angiography (CCTA) and magnetic resonance imaging (MRI) and lab-based techniques, provides a powerful combination to advance both research and ultimately clinical care. In this review, we demonstrate how molecular imaging studies, specifically using 18-FDG PET, have revealed that early vascular disease is a systemic process with multiple, concurrent biological mechanisms using inflammatory diseases as a basis to understand early atherosclerotic mechanisms in humans.

Citing Articles

Is there an association between coronary artery inflammation and coronary atherosclerotic burden?.

Jing M, Xi H, Zhu H, Zhang X, Xu Z, Wu S Quant Imaging Med Surg. 2023; 13(9):6048-6058.

PMID: 37711803 PMC: 10498248. DOI: 10.21037/qims-23-147.

PET/MR imaging of inflammation in atherosclerosis.

Senders M, Calcagno C, Tawakol A, Nahrendorf M, Mulder W, Fayad Z Nat Biomed Eng. 2022; 7(3):202-220.

PMID: 36522465 DOI: 10.1038/s41551-022-00970-7.

Advances in Radiopharmaceutical Sciences for Vascular Inflammation Imaging: Focus on Clinical Applications.

Prigent K, Vigne J Molecules. 2021; 26(23).

PMID: 34885690 PMC: 8659223. DOI: 10.3390/molecules26237111.

Heightened splenic and bone marrow uptake of F-FDG PET/CT is associated with systemic inflammation and subclinical atherosclerosis by CCTA in psoriasis: An observational study.

Patel N, Osborne M, Teague H, Parel P, Svirydava M, Sorokin A Atherosclerosis. 2021; 339:20-26.

PMID: 34808541 PMC: 8723715. DOI: 10.1016/j.atherosclerosis.2021.11.008.

Biomarkers of subclinical atherosclerosis in patients with psoriasis.

Kaiser H, Wang X, Kvist-Hansen A, Krakauer M, Gortz P, McCauley B Sci Rep. 2021; 11(1):21438.

PMID: 34728734 PMC: 8564536. DOI: 10.1038/s41598-021-00999-9.

References

Rose S, Dave J, Millo C, Naik H, Siegel E, Mehta N . Psoriatic arthritis and sacroiliitis are associated with increased vascular inflammation by 18-fluorodeoxyglucose positron emission tomography computed tomography: baseline report from the Psoriasis Atherosclerosis and Cardiometabolic Disease.... Arthritis Res Ther. 2014; 16(4):R161. PMC: 4261785. DOI: 10.1186/ar4676. View

Vallabhajosula S, Fuster V . Atherosclerosis: imaging techniques and the evolving role of nuclear medicine. J Nucl Med. 1997; 38(11):1788-96. View

Jankord R, Herman J . Limbic regulation of hypothalamo-pituitary-adrenocortical function during acute and chronic stress. Ann N Y Acad Sci. 2009; 1148:64-73. PMC: 2637449. DOI: 10.1196/annals.1410.012. View

Fayad Z, Mani V, Woodward M, Kallend D, Abt M, Burgess T . Safety and efficacy of dalcetrapib on atherosclerotic disease using novel non-invasive multimodality imaging (dal-PLAQUE): a randomised clinical trial. Lancet. 2011; 378(9802):1547-59. PMC: 4151875. DOI: 10.1016/S0140-6736(11)61383-4. View

Naik H, Natarajan B, Stansky E, Ahlman M, Teague H, Salahuddin T . Severity of Psoriasis Associates With Aortic Vascular Inflammation Detected by FDG PET/CT and Neutrophil Activation in a Prospective Observational Study. Arterioscler Thromb Vasc Biol. 2015; 35(12):2667-76. PMC: 4662627. DOI: 10.1161/ATVBAHA.115.306460. View

Singh P, Emami H, Subramanian S, Maurovich-Horvat P, Marincheva-Savcheva G, Medina H . Coronary Plaque Morphology and the Anti-Inflammatory Impact of Atorvastatin: A Multicenter 18F-Fluorodeoxyglucose Positron Emission Tomographic/Computed Tomographic Study. Circ Cardiovasc Imaging. 2016; 9(12). PMC: 5175997. DOI: 10.1161/CIRCIMAGING.115.004195. View

Brauchli Y, Jick S, Miret M, Meier C . Psoriasis and risk of incident myocardial infarction, stroke or transient ischaemic attack: an inception cohort study with a nested case-control analysis. Br J Dermatol. 2009; 160(5):1048-56. DOI: 10.1111/j.1365-2133.2008.09020.x. View

Chen I, Wu J . Cardiovascular molecular imaging: focus on clinical translation. Circulation. 2011; 123(4):425-43. PMC: 3073678. DOI: 10.1161/CIRCULATIONAHA.109.916338. View

Rudd J, Myers K, Bansilal S, Machac J, Pinto C, Tong C . Atherosclerosis inflammation imaging with 18F-FDG PET: carotid, iliac, and femoral uptake reproducibility, quantification methods, and recommendations. J Nucl Med. 2008; 49(6):871-8. DOI: 10.2967/jnumed.107.050294. View

10.

Goyal A, Dey A, Chaturvedi A, Elnabawi Y, Aberra T, Chung J . Chronic Stress-Related Neural Activity Associates With Subclinical Cardiovascular Disease in Psoriasis: A Prospective Cohort Study. JACC Cardiovasc Imaging. 2018; 13(2 Pt 1):465-477. PMC: 6506409. DOI: 10.1016/j.jcmg.2018.08.038. View

11.

Teague H, Aksentijevich M, Stansky E, Silverman J, Varghese N, Dey A . Cells of Myeloid Origin Partly Mediate the Association between Psoriasis Severity and Coronary Plaque. J Invest Dermatol. 2019; 140(4):912-915.e1. PMC: 7428866. DOI: 10.1016/j.jid.2019.07.724. View

12.

Avina-Zubieta J, Choi H, Sadatsafavi M, Etminan M, Esdaile J, Lacaille D . Risk of cardiovascular mortality in patients with rheumatoid arthritis: a meta-analysis of observational studies. Arthritis Rheum. 2008; 59(12):1690-7. DOI: 10.1002/art.24092. View

13.

Rudd J, Myers K, Bansilal S, Machac J, Rafique A, Farkouh M . (18)Fluorodeoxyglucose positron emission tomography imaging of atherosclerotic plaque inflammation is highly reproducible: implications for atherosclerosis therapy trials. J Am Coll Cardiol. 2007; 50(9):892-6. DOI: 10.1016/j.jacc.2007.05.024. View

14.

Elnabawi Y, Dey A, Goyal A, Groenendyk J, Chung J, Belur A . Coronary artery plaque characteristics and treatment with biologic therapy in severe psoriasis: results from a prospective observational study. Cardiovasc Res. 2019; 115(4):721-728. PMC: 6432047. DOI: 10.1093/cvr/cvz009. View

15.

Tawakol A, Ishai A, Takx R, Figueroa A, Ali A, Kaiser Y . Relation between resting amygdalar activity and cardiovascular events: a longitudinal and cohort study. Lancet. 2017; 389(10071):834-845. PMC: 7864285. DOI: 10.1016/S0140-6736(16)31714-7. View

16.

Libby P . Mechanisms of acute coronary syndromes and their implications for therapy. N Engl J Med. 2013; 368(21):2004-13. DOI: 10.1056/NEJMra1216063. View

17.

Emami H, Tawakol A . Noninvasive imaging of arterial inflammation using FDG-PET/CT. Curr Opin Lipidol. 2014; 25(6):431-7. DOI: 10.1097/MOL.0000000000000135. View

18.

Mehta N, Krishnamoorthy P, Yu Y, Khan O, Raper A, Van Voorhees A . The impact of psoriasis on 10-year Framingham risk. J Am Acad Dermatol. 2012; 67(4):796-8. PMC: 3444673. DOI: 10.1016/j.jaad.2012.05.016. View

19.

Lateef S, Al Najafi M, Dey A, Batool M, Abdelrahman K, Uceda D . Relationship between chronic stress-related neural activity, physiological dysregulation and coronary artery disease in psoriasis: Findings from a longitudinal observational cohort study. Atherosclerosis. 2020; 310:37-44. PMC: 7587126. DOI: 10.1016/j.atherosclerosis.2020.07.012. View

20.

Lerman J, Joshi A, Chaturvedi A, Aberra T, Dey A, Rodante J . Coronary Plaque Characterization in Psoriasis Reveals High-Risk Features That Improve After Treatment in a Prospective Observational Study. Circulation. 2017; 136(3):263-276. PMC: 5534138. DOI: 10.1161/CIRCULATIONAHA.116.026859. View